Bavarian Nordic A/S (CPH:BAVA)
Denmark
· Delayed Price · Currency is DKK 190.35
-1.50 (-0.78%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| Life-Saving Vaccines | 5.72B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life-Saving Vaccines Growth | -19.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rabipur/RabAvert | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| MVA-BN Smallpox Vaccine | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| MVA-BN Smallpox Vaccine Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Encepur | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Contract Work | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Contract Work Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Milestone Payments | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| United States | 2.70B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 4.88% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany | 972.76M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany Growth | 36.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada | 493.21M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada Growth | -68.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| France | 268.77M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| France Growth | -63.69% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Saudi Arabia | 265.73M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Belgium | 218.19M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Belgium Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Singapore | 124.65M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finland | 98.47M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Netherlands | 69.79M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Netherlands Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 501.74M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 8.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Spain | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Australia | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Australia Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Switzerland | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Switzerland Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sweden | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sweden Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chile | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hong Kong | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Austria | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Austria Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Denmark | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|